On Our Radar: Deals we are paying attention to for their impact on industry. CMS Medical Venture Investment has bought a quarter of Midatech Pharma Plc’s stock outstanding, reported Bloomberg on April 8. Both are specialty pharmaceutical companies, with CMS owned by a holding company. The venture capital held 104 million shares, according to Midatech Pharma's […]

THIS ARTICLE IS EXCLUSIVE FOR KARMA MEMBERS

If you are an existing Karma member, please login using the form below.

If you are a guest, you can access this article - plus much more - with our 7-day FREE trial. Click here to register. No credit card required.